Procaps (PROCW) Stock Analysis

What Procaps does

Procaps Group, S.A. operates as a globally integrated healthcare and pharmaceutical enterprise. The company is actively involved in the development, production, and distribution of branded prescription medications across numerous therapeutic domains, including women's health, pain management, dermatology, digestive wellness, growth and development, cardiovascular health, ophthalmology, central nervous system disorders, and respiratory ailments. Additionally, it supplies a range of pharmaceuticals for hospital use, such as antibiotics, anticoagulants, personal protective equipment, immunosuppressants, oncology treatments, and analgesics. Procaps also offers an extensive portfolio of over-the-counter (OTC) consumer healthcare products, covering approximately ten distinct therapeutic categories. These include gastrointestinal health, skincare, cough and cold remedies, pain relief, urological support, and various vitamins, minerals, and dietary supplements. Further specialized areas encompass anti-infective agents, cardiovascular medications, feminine care products, cutaneous antimycotics, hormonal treatments, metabolic and endocrine solutions, nervous system drugs, ophthalmic preparations, osteoarticular therapies, and respiratory aids. Beyond its core pharmaceutical offerings, the company provides comprehensive diabetes management solutions, including blood glucose meters, telemonitoring systems, oral antidiabetics, and insulin delivery devices, alongside cosmeceuticals and other related products. Furthermore, Procaps extends its capabilities to third-party pharmaceutical companies by offering contract drug development and manufacturing services, with a specific expertise in soft gelatin capsule technologies. Founded in 1977, the company is headquartered in Luxembourg City, Luxembourg.

Key metrics

ETFs linked to PROCW

Broad-market and Healthcare sector ETFs an investor holding Procaps is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PROCW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Procaps?

Procaps trades under the ticker PROCW on NASDAQ.

Which exchange is PROCW listed on?

PROCW is listed on NASDAQ.

What sector does Procaps operate in?

Procaps is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze PROCW in a portfolio?

PortView shows PROCW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.